Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07734090 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Natural History of MADD

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 4 more changesShow less
    • Start date: Jul 2026 to Oct 2026
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised at 2 of 2 sites
    • Eligibility criteria expanded, about 2 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to conduct a longitudinal, observational investigation to determine the natural history of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD), delineate the spectrum of its clinical features and their progression, identify biomarkers, and develop and validate patient reported outcomes.
Trial Details
NCT Number NCT07734090
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions
(from sponsor)		 Multiple Acyl-CoA Dehydrogenase Deficiency
Related terms Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov